ABVC BioPharma, Inc. Impairment of Intangible Assets (Excluding Goodwill)
ABVC BioPharma, Inc. (ABVC) reported Impairment of Intangible Assets (Excluding Goodwill) of $43.65 million for the 0-month period ending 2019-02-08, per its 10-Q filed 2022-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill · last filed 2022-11-14
- 2019-02-08: Impairment of Intangible Assets (Excluding Goodwill) 0 month $43.65M.
| Period end | Impairment of Intangible Assets (Excluding Goodwill) 0 month |
|---|---|
| 2019-02-08 | $43.65M 10-Q · filed 2022-11-14 |